GGHC
CMIIU

Gilder Gagnon Howe & Co’s CM Life Sciences II Inc. Unit CMIIU Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio CMIIU Stock Details CMIIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-74,570
Closed -$954K – 455
2021
Q1 		$954K Buy
+74,570
New +$936K 0.01% 299

Other funds holding CMIIU

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $4.67B AUM 83.55% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
IM
Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return

Gilder Gagnon Howe & Co's CMIIU Position: Q2 2021 in Review

Gilder Gagnon Howe & Co sold out of CM Life Sciences II Inc. Unit (CMIIU) in Q2 2021, closing a stake of 74,570 shares — an estimated $954K sold.

Gilder Gagnon Howe & Co first reported a position in CMIIU in Q1 2021 and held it in 1 quarter. The position peaked at $954K in Q1 2021. 38 funds tracked by Wall St. Rank hold CMIIU as of Q2 2021.

  • Gilder Gagnon Howe & Co reported no remaining CM Life Sciences II Inc. Unit position as of Q2 2021 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 74,570 CM Life Sciences II Inc. Unit shares in Q2 2021, an estimated $954K.
  • Gilder Gagnon Howe & Co first reported a position in CM Life Sciences II Inc. Unit in Q1 2021 and held it in 1 quarter.
  • Gilder Gagnon Howe & Co's CM Life Sciences II Inc. Unit position peaked at $954K in Q1 2021.
  • 38 funds tracked by Wall St. Rank held CM Life Sciences II Inc. Unit as of Q2 2021.

Based on Gilder Gagnon Howe & Co's 13F filing for Q2 2021, filed 16 Aug 2021.